Pacer Advisors’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.16M | Sell |
11,948
-88
| -0.7% | -$9.03K | ﹤0.01% | 1151 |
|
|
2025
Q4 | $1.28M | Sell |
12,036
-4,133
| -26% | -$479K | ﹤0.01% | 1323 |
|
|
2025
Q3 | $2.05M | Buy |
16,169
+12,236
| +311% | +$1.46M | 0.01% | 1055 |
|
|
2025
Q2 | $482K | Sell |
3,933
-377
| -9% | -$43.1K | ﹤0.01% | 1430 |
|
|
2025
Q1 | $437K | Sell |
4,310
-15,316
| -78% | -$1.5M | ﹤0.01% | 1516 |
|
|
2024
Q4 | $1.81M | Buy |
19,626
+377
| +2% | +$37K | ﹤0.01% | 1062 |
|
|
2024
Q3 | $1.86M | Sell |
19,249
-394
| -2% | -$35.4K | ﹤0.01% | 1027 |
|
|
2024
Q2 | $1.69M | Buy |
19,643
+888
| +5% | +$74.5K | ﹤0.01% | 1017 |
|
|
2024
Q1 | $1.55M | Sell |
18,755
-2,873
| -13% | -$210K | ﹤0.01% | 979 |
|
|
2023
Q4 | $1.44M | Buy |
21,628
+10,702
| +98% | +$693K | ﹤0.01% | 933 |
|
|
2023
Q3 | $734K | Sell |
10,926
-6,674
| -38% | -$459K | ﹤0.01% | 967 |
|
|
2023
Q2 | $1.19M | Buy |
+17,600
| New | +$1.1M | ﹤0.01% | 983 |
|
|
2023
Q1 | – | Sell |
-19,126
| Closed | -$1.14M | – | 2241 |
|
|
2022
Q4 | $1.14M | Buy |
+19,126
| New | +$1.04M | 0.01% | 760 |
|
|
2022
Q1 | – | Sell |
-12,989
| Closed | -$674K | – | 2354 |
|
|
2021
Q4 | $674K | Buy |
12,989
+159
| +1% | +$8.2K | 0.01% | 1420 |
|
|
2021
Q3 | $766K | Sell |
12,830
-317
| -2% | -$19.9K | 0.01% | 970 |
|
|
2021
Q2 | $816K | Sell |
13,147
-156
| -1% | -$10.4K | 0.01% | 931 |
|
|
2021
Q1 | $867K | Sell |
13,303
-633
| -5% | -$41.3K | 0.02% | 833 |
|
|
2020
Q4 | $917K | Sell |
13,936
-16,223
| -54% | -$954K | 0.02% | 745 |
|
|
2020
Q3 | $1.56M | Buy |
+30,159
| New | +$1.55M | 0.03% | 510 |
|
|
2020
Q1 | – | Sell |
-42,602
| Closed | -$2.35M | – | 798 |
|
|
2019
Q4 | $2.35M | Sell |
42,602
-3,643
| -8% | -$198K | 0.11% | 225 |
|
|
2019
Q3 | $2.33M | Sell |
46,245
-3,600
| -7% | -$181K | 0.05% | 421 |
|
|
2019
Q2 | $2.51M | Buy |
+49,845
| New | +$2.42M | 0.06% | 370 |
|
|
2018
Q4 | – | Sell |
-42,345
| Closed | -$2.63M | – | 694 |
|
|
2018
Q3 | $2.63M | Buy |
42,345
+3,051
| +8% | +$186K | 0.1% | 222 |
|
|
2018
Q2 | $2.12M | Buy |
39,294
+5,722
| +17% | +$286K | 0.1% | 247 |
|
|
2018
Q1 | $1.53M | Buy |
33,572
+3,581
| +12% | +$154K | 0.08% | 296 |
|
|
2017
Q4 | $1.18M | Buy |
29,991
+10,662
| +55% | +$406K | 0.08% | 340 |
|
|
2017
Q3 | $713K | Buy |
19,329
+4,411
| +30% | +$157K | 0.06% | 456 |
|
|
2017
Q2 | $574K | Buy |
14,918
+884
| +6% | +$32.4K | 0.06% | 522 |
|
|
2017
Q1 | $478K | Buy |
14,034
+2,545
| +22% | +$83.6K | 0.06% | 499 |
|
|
2016
Q4 | $377K | Buy |
11,489
+1,469
| +15% | +$47.7K | 0.05% | 556 |
|
|
2016
Q3 | $323K | Buy |
10,020
+845
| +9% | +$27.4K | 0.05% | 560 |
|
|
2016
Q2 | $283K | Buy |
+9,175
| New | +$287K | 0.04% | 601 |
|
Other funds holding EHC
VPM
VCM
Pacer Advisors's EHC Position: Q1 2026 in Review
Pacer Advisors reduced its Encompass Health (EHC) stake by 0.73% in Q1 2026, selling an estimated $9.03K and leaving 11,948 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1151.
Pacer Advisors first reported a position in EHC in Q2 2016 and has held it in 32 quarters since. The position peaked at $2.63M in Q3 2018. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Pacer Advisors held 11,948 shares of Encompass Health worth $1.16M as of Q1 2026.
- Pacer Advisors sold 88 Encompass Health shares in Q1 2026, an estimated $9.03K.
- Encompass Health made up ﹤0.01% of Pacer Advisors's portfolio in Q1 2026, its #1151 holding.
- Pacer Advisors first reported a position in Encompass Health in Q2 2016 and has held it in 32 quarters since.
- Pacer Advisors's Encompass Health position peaked at $2.63M in Q3 2018.
- 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.